SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-003423
Filing Date
2022-02-02
Accepted
2022-02-01 18:14:23
Documents
12
Period of Report
2022-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K isco-8k_20220201.htm   iXBRL 8-K 34290
  Complete submission text file 0001564590-22-003423.txt   147962

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA isco-20220201.xsd EX-101.SCH 5745
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20220201_lab.xml EX-101.LAB 16619
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20220201_pre.xml EX-101.PRE 9879
6 EXTRACTED XBRL INSTANCE DOCUMENT isco-8k_20220201_htm.xml XML 3056
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 22580559
SIC: 2834 Pharmaceutical Preparations